Voisin; Thierry

Patent Applications and Registrations

Patent applications and USPTO patent grants for Voisin; Thierry.The latest application filed is for "methods and pharmaceutical compositions for the treatment of autoimmune inflammatory".

Company Profile

4.3.12

Voisin; Thierry - Paris FR
VOISIN; Thierry - Paris Cedex 18 FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods and pharmaceutical compositions for the treatment of cancer Grant 10,894,042 - Couvineau , et al. January 19, 2	2021-01-19
Human monoclonal antibodies against orexin receptor type 1 Grant 10,758,615 - Couvineau , et al. Sep	2020-09-01
Methods And Pharmaceutical Compositions For The Treatment Of Autoimmune Inflammatory App 20190151304 - TAN; Yossan-Var ; et al.	2019-05-23
Use Of Ox1r Antagonists For The Treatment Of Inflammatory Bowel Diseases App 20190083508 - COUVINEAU; Alain ; et al.	2019-03-21
Method of treating an inflammatory bowel disease comprising agonists of orexin-1 receptor Grant 10,172,921 - Couvineau , et al. J	2019-01-08
Methods And Pharmaceutical Compositions For The Treatment Of Hepatocellular Carcinomas App 20180339022 - COUVINEAU; Alain ; et al.	2018-11-29
Methods And Pharmaceutical Compositions For The Treatment Of Autoimmune Inflammatory Diseases App 20180305458 - TAN; Yossan-Var ; et al.	2018-10-25
Methods And Pharmaceutical Compositions For The Treatment Of Cancer App 20180296549 - COUVINEAU; Alain ; et al.	2018-10-18
Methods And Pharmaceutical Compositions For The Treatment Of Pancreatic Cancer App 20180064789 - VOISIN; Thierry ; et al.	2018-03-08
Orexin-b Polypeptides And Uses Thereof App 20180044393 - COUVINEAU; Alain ; et al.	2018-02-15
Human Monoclonal Antibodies Against Orexin Receptor Type 1 App 20180030135 - COUVINEAU; Alain ; et al.	2018-02-01
Human Monoclonal Antibodies Against Orexin Receptor Type 1 App 20180002421 - COUVINEAU; Alain ; et al.	2018-01-04
Methods and Pharmaceutical Compositions Using Orexins (OXA, OXB) for the Treatment of Prostate Cancers App 20170319661 - Chartrel; Nicolas ; et al.	2017-11-09
Pharmaceutical Compositions Comprising Agonists Of Orexin-1 Receptor Ox1r For The Treatment Of Inflammatory Bowel Diseases App 20170202925 - COUVINEAU; Alain ; et al.	2017-07-20
Methods And Pharmaceutical Compositions For The Treatment Of Hepatocellular Carcinomas App 20160339080 - COUVINEAU; Alain ; et al.	2016-11-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.